Lu J - Search Results

1

VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo.

Zhai Y, Ni J, Jiang GW, Lu J, Xing L, Lincoln C, Carter KC, Janat F, Kozak D, Xu S, Rojas L, Aggarwal BB, Ruben S, Li LY, Gentz R, Yu GL. Zhai Y, et al. Among authors: lu j. FASEB J. 1999 Jan;13(1):181-9. doi: 10.1096/fasebj.13.1.181. FASEB J. 1999. PMID: 9872942

2

LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer.

Zhai Y, Guo R, Hsu TL, Yu GL, Ni J, Kwon BS, Jiang GW, Lu J, Tan J, Ugustus M, Carter K, Rojas L, Zhu F, Lincoln C, Endress G, Xing L, Wang S, Oh KO, Gentz R, Ruben S, Lippman ME, Hsieh SL, Yang D. Zhai Y, et al. Among authors: lu j. J Clin Invest. 1998 Sep 15;102(6):1142-51. doi: 10.1172/JCI3492. J Clin Invest. 1998. PMID: 9739048 Free PMC article.

3

Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily.

Zhai Y, Yu J, Iruela-Arispe L, Huang WQ, Wang Z, Hayes AJ, Lu J, Jiang G, Rojas L, Lippman ME, Ni J, Yu GL, Li LY. Zhai Y, et al. Among authors: lu j. Int J Cancer. 1999 Jul 2;82(1):131-6. doi: 10.1002/(sici)1097-0215(19990702)82:1<131::aid-ijc22>3.0.co;2-o. Int J Cancer. 1999. PMID: 10360832

4

Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake.

Jiang C, Jiang W, Ip C, Ganther H, Lu J. Jiang C, et al. Among authors: lu j. Mol Carcinog. 1999 Dec;26(4):213-25. doi: 10.1002/(sici)1098-2744(199912)26:4<213::aid-mc1>3.0.co;2-z. Mol Carcinog. 1999. PMID: 10569799

5

[Clinical use of acellular allogenic dermis or acellular porcine dermis with split-thickness autologous skin graft in 119 cases].

Chai J, Yang H, Li L, Guo Z, Sheng Z, Xu M, Chen B, Jia X, Jing S, Lu J, Li G. Chai J, et al. Among authors: lu j. Zhonghua Wai Ke Za Zhi. 2000 Oct;38(10):790-3. Zhonghua Wai Ke Za Zhi. 2000. PMID: 11832167 Chinese.

6

Apoptosis and angiogenesis in cancer prevention by selenium.

Lu J. Lu J. Adv Exp Med Biol. 2001;492:131-45. doi: 10.1007/978-1-4615-1283-7_11. Adv Exp Med Biol. 2001. PMID: 11480662 Review. No abstract available.

7

Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells.

Jiang C, Agarwal R, Lü J. Jiang C, et al. Among authors: lu j. Biochem Biophys Res Commun. 2000 Sep 16;276(1):371-8. doi: 10.1006/bbrc.2000.3474. Biochem Biophys Res Commun. 2000. PMID: 11006131

8

Monomethyl selenium--specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation.

Jiang C, Ganther H, Lu J. Jiang C, et al. Among authors: lu j. Mol Carcinog. 2000 Dec;29(4):236-50. doi: 10.1002/1098-2744(200012)29:4<236::aid-mc1006>3.0.co;2-e. Mol Carcinog. 2000. PMID: 11170262

9

[High efficiency expression of IL-4 using modified cDNA expression vector in mammalian cells].

Wang Z, Tian C, Liu L, Xu M, Lu J. Wang Z, et al. Among authors: lu j. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1995 Jun;17(3):183-7. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1995. PMID: 8706152 Chinese.

10

Antiangiogenic activity of selenium in cancer chemoprevention: metabolite-specific effects.

Lu J, Jiang C. Lu J, et al. Nutr Cancer. 2001;40(1):64-73. doi: 10.1207/S15327914NC401_12. Nutr Cancer. 2001. PMID: 11799926 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,054 results

Search Page

Filters